age1 leads Series C as Loyal advances LOY-002 toward FDA approval, completing key requirements for conditional approval.

vist.ly/4r96v

#longevity #CanineHealth #VeterinaryMedicine #BiotechFunding #HealthyAging #FDAApproval #PetLongevity #DrugDevelopment

Loyal’s lead drug for senior dogs moves closer to market, marking a rare regulatory milestone for lifespan extension.

longevity.technology/news/fda-cle...

#longevity #CanineHealth #PetLongevity #FDA #HealthyAging #BioInnovation #LongevityScience

Gallant fetches $18m to advance regenerative medicine for pets Pet longevity biotech boasts stem cell therapies for dogs and cats, targeting osteoarthritis, atopic dermatitis and chronic kidney disease.

Gallant fetches $18m to advance regenerative medicine for pets
Pet longevity biotech boasts stem cell therapies for dogs and cats, targeting osteoarthritis, atopic dermatitis and chronic kidney disease.
#longevity #pets #investment #petlongevity

Loyal’s Revolutionary Approach to Pet Longevity For many, pets aren't just companions; they're family. The bond we share with our dogs and cats is profound, making the inevitable brevity of their lifespans a source of deep sorrow. But what if we could extend those precious years? Enter Loyal, a pioneering biotech company dedicated to revolutionizing pet longevity. Loyal isn't just about wishful thinking; it's grounded in cutting-edge science.

Imagine more years with your beloved dog! 🐾 Loyal is working to extend pet longevity through groundbreaking biotech. Learn how they're changing the future for our furry companions. #PetLongevity #Biotech #Dogs